Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Certified by Founder
Lodge
NVision Imaging Technologies
start up
Germany
- Ulm, Baden-Württemberg
- 26/06/2023
- Series A
- $30,000,000
NVision is a developer of MRI polarizers and hyperpolarized imaging agents. The company’s hyperpolarization technology permits the assessment of human and animal metabolism by standard MRI, enabling advanced preclinical and clinical applications, including novel cancer diagnosis and monitoring of response to therapy. 2023 delivery of first polarizers to users.
- Industry Nanotechnology Research
- Website https://www.nvision-imaging.com/
- LinkedIn https://www.linkedin.com/company/nvision-imaging-technologies/
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
KeySavvy | $4,250,000 | (Nov 22, 2024)
Prompt Security | $18,000,000 | (Nov 21, 2024)